Cutaneous infection due to a Runyon group 3 atypical Mycobacterium.
D000328:Adult; D001706:Biopsy; D003523:Cycloserine / Q000008:administration & dosage / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D005533:Foot Dermatoses / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D009161:Mycobacterium / Q000302:isolation & purification; D009164:Mycobacterium Infections / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D012867:Skin / Q000473:pathology; D012874:Skin Diseases, Infectious / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D013307:Streptomycin / Q000008:administration & dosage / Q000627:therapeutic use
D003523:Cycloserine; D007538:Isoniazid; D013307:Streptomycin